Skip to main content

NTB Financial Corp

SEC CIK
0001910010
Latest filing
Aug 9, 2022

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by NTB Financial Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overviewAll 13F holders of CLDXFull Q2 2022 holdings

Shares (Q2 2022)
0
Sold out in Q2 2022
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q4 2021
Holdings of CLDX by NTB Financial Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20220$00.0%−6,895−100.0%Sold outHolders
Q1 20226,895$235.0K0.2%00.0%UnchangedHolders
Q4 20216,895$266.0K0.2%–No prior filingHolders